Chemical Research in Chinese Universities ›› 2019, Vol. 35 ›› Issue (3): 434-439.doi: 10.1007/s40242-019-8184-8

• Articles • Previous Articles     Next Articles

Delivery of Survivin siRNA Using Cationic Diphenylalanine Vesicles

GUAN Shuwen1, YU Xiaoxuan1, LI Junyang1, XU Heng2, HAN Wenzhao1, SHI Guannan1, XU Jia1, WANG Liping1   

  1. 1. School of Life Sciences, Jilin University, Changchun 130012, P. R. China;
    2. College of Chemistry, Jilin University, Changchun 130012, P. R. China
  • Received:2018-05-31 Revised:2019-04-04 Online:2019-06-01 Published:2019-05-29
  • Contact: WANG Liping E-mail:wanglp@jlu.edu.cn
  • Supported by:
    Supported by the Science and Technology Development Program of Jilin Province, China(No.20150520157JH).

Abstract: Small interfering RNA(siRNA) has been proved to be a powerful tool for silencing target gene in cells, raising the possibility that siRNA can be employed as a therapy for treating cancers and other genetic diseases. However, siRNA transfection has the limitation due to the difficulty in the delivery of siRNA to target cells and tissues. To explore an efficient biocompatible siRNA delivery system, cationic diphenylalanine vesicles(CDPVs) were constructed to transfer survivin siRNA to human ovarian cancer cells. The morphology of CDPVs was characterized by scanning electron microscopy(SEM) and the distribution of survivin siRNA was characterized by confocal laser scanning microscopy, which reveal that diphenylalanine and the survivin siRNA were successfully co-delivered. After co-incubation for 48 h, the CDPVs/siRNA exhibited enhanced tumor cell growth inhabitation and apoptosis inducted in human SK-OV-3 ovarian carcinoma cells. Overall, CDPVs is an efficient siRNA delivery system and has a pro- mising prospect for cancer therapy.

Key words: siRNA delivery, Cationic diphenylalanine nanovesicle, Cancer therapy